Related Experiment Video
Updated: Apr 28, 2026
Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
Detection of stealthy small amphiphilic biomarkers
Rama Murthy Sakamuri1, Petr Capek2, Tobin J Dickerson2
1Chemistry Division, MS J567, Los Alamos National Laboratory, Los Alamos, NM 87544, United States.
Abstract:
Pathogen-specific biomarkers are secreted in the host during infection. Many important biomarkers are not proteins but rather small molecules that cannot be directly detected by conventional methods. However, these small molecule biomarkers, such as phenolic glycolipid-I (PGL-I) of Mycobacterium leprae and Mycobactin T (MbT) of Mycobacterium tuberculosis, are critical to the pathophysiology of infection, and may be important in the development of diagnostics, vaccines, and novel therapeutic strategies. Methods for the direct detection of these biomarkers may be of significance both for the diagnosis of infectious disease, and also for the laboratory study of such molecules. Herein, we present, for the first time, a transduction approach for the direct and rapid (30min) detection of small amphiphilic biomarkers in complex samples (e.g. serum) using a single affinity reagent. To our knowledge, this is the first demonstration of an assay for the direct detection of PGL-I, and the first single-reporter assay for the detection of MbT. The assay format exploits the amphiphilic chemistry of the small molecule biomarkers, and is universally applicable to all amphiphiles. The assay is only the first step towards developing a robust system for the detection of amphiphilic biomarkers that are critical to infectious disease pathophysiology.
Insights
This study introduces a novel assay for rapidly detecting small molecule biomarkers, like phenolic glycolipid-I (PGL-I) and Mycobactin T (MbT), crucial for diagnosing infectious diseases. The method offers a significant advancement for identifying these critical pathogen markers in complex samples.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Infectious Diseases
Background:
- Pathogen infections involve small molecule biomarkers, not just proteins.
- Conventional methods struggle to detect these critical non-protein biomarkers.
- Phenolic glycolipid-I (PGL-I) and Mycobactin T (MbT) are key examples.
Purpose of the Study:
- To develop a direct, rapid detection method for small amphiphilic biomarkers.
- To enable the study and diagnosis of infections caused by pathogens secreting these molecules.
- To create a universally applicable assay for amphiphilic biomarkers.
Main Methods:
- A novel transduction approach using a single affinity reagent.
- Exploitation of the amphiphilic chemistry of small molecule biomarkers.
- Application to complex biological samples like serum.
Main Results:
- First direct detection assay for PGL-I.
- First single-reporter assay for MbT.
- Rapid (30-minute) detection achieved.
Conclusions:
- The developed assay is the first to directly detect PGL-I and MbT.
- The method is universally applicable to amphiphilic biomarkers.
- This represents a significant step towards robust detection systems for infectious disease biomarkers.
